Larimar Therapeutics, Inc. (LRMR) Covered Calls

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. The company's lead compound is CTI-1601, a Phase 1 clinical program to treat Friedreich's ataxia, a rare and progressive genetic disease. The company is headquartered in Bala Cynwyd, Pennsylvania.

You can sell covered calls on Larimar Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for LRMR (prices last updated Fri 4:16 PM ET):

Larimar Therapeutics, Inc. (LRMR) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
2.97	+0.11	2.83	2.97	2.1M	-	0.2

Covered Calls For Larimar Therapeutics, Inc. (LRMR)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
May 16	2.5	0.50	2.47	1.2%	29.2%
Jun 20	2.5	0.55	2.42	3.3%	24.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Top 10 Open Interest For May 16 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	IWM covered calls	1.	APP covered calls
2.	SPY covered calls	7.	FXI covered calls	2.	CVI covered calls
3.	TLT covered calls	8.	GLD covered calls	3.	PTON covered calls
4.	SLV covered calls	9.	TSLA covered calls	4.	PINS covered calls
5.	QQQ covered calls	10.	INTC covered calls	5.	UPST covered calls

Want more examples? LRGF Covered Calls | LRN Covered Calls